Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADaptive ASsessment of TReatments for influenzA: A Phase 2 Multi-centre Adaptive Randomised Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic Influenza Infection (AD ASTRA)

NCT05648448 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05648448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05648448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADaptive ASsessment of TReatments for influenzA: A Phase 2 Multi-centre Adaptive Randomised Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic Influenza Infection (AD ASTRA)
Lead sponsor
University of Oxford
Phase
Phase 2
Overall status
Recruiting
Start date
February 22, 2023
Completion date
January 1, 2027
Enrollment
3,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, influenza, human